insights_auto
Sebab 8NE menurun 4.22%?
Terokai Dengan Lebih Terperincichevron_right
8NE:FRA
Lisata Therapeutics, Inc.
€0.80
arrow_downward
-4.22%(-0.035) 1H
19 Okt, 10:00:00 PTG GMT+2 · EUR
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk 8NE...
Buka
€0.80
Tinggi
€0.80
Rendah
€0.80
Permodalan Pasaran
10.80J
Purata volum
0.00
Volum
0.00
tgi 52 mgu
€4.34
rdh 52 mgu
€0.74
Bilangan pekerja
21
Buka
€0.80
Tinggi
€0.80
Rendah
€0.80
Permodalan Pasaran
10.80J
Purata volum
0.00
Volum
0.00
tgi 52 mgu
€4.34
rdh 52 mgu
€0.74
Bilangan pekerja
21
Cerita berita
Daripada sumber web dan rakan kongsi berita
Investing.com Canada
·
16 jam lalu
Form DEF 14A Lisata Therapeutics For: 19 October By Investing.com
Profil
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Perihal Lisata Therapeutics, Inc.
CEO-
Pekerja21
Diasaskan1980
Ibu pejabatBasking Ridge, New Jersey, Amerika Syarikat
Sektor-
Laman weblisata.com